Vertebral Augmentation Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR (2024 - 2029) | 4.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Vertebral Augmentation Market Analysis
The Vertebral Augmentation Market is expected to register a CAGR of 4.20% during the forecast period.
Factors such as the high prevalence of osteoporosis and injuries due to accidents and sports, the rising geriatric population, technological advancements, and ongoing research in the area are expected to drive the market's growth over the forecast period.
The increasing number of osteoporosis cases among the population is a key factor driving market growth. For instance, according to the 2022 data published by the International Osteoporosis Foundation, one in three women over 50 years and one in five men are likely to experience osteoporotic fractures in their lifetime. As per the same source, osteoporosis would be responsible for three million fractures, resulting in USD 25.3 billion in costs per year by 2025. Thus, the expected increase in fractures caused by osteoporosis is anticipated to fuel the demand for kyphoplasty/vertebroplasty procedures, propelling market growth.
Similarly, the growing incidence of sports injuries and accidents contributes to a rise in the number of vertebral augmentation procedures globally, which is expected to drive the market over the study period. For instance, according to data published by the United Kingdom Spinal Injury Association in May 2024, approximately 4,400 individuals sustain spinal cord injuries in the United Kingdom each year, contributing to an estimated 105 thousand people currently living with such injuries.
Furthermore, the increasing aging population is more prone to develop osteoporosis, raising the risk of vertebral compression fractures and causing significant pain and inability to perform daily life activities. For instance, according to the World Health Organization’s (WHO) Ageing and Health report in October 2022, the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. This, in turn, is expected to increase the need for surgical procedures to reduce pain and further collapse the vertebral body, thereby bolstering market growth.
Therefore, the market studied is anticipated to grow over the forecast period due to the high number of road and sports injuries, rising incidences of osteoporosis, the increasing geriatric population, and new product launches. However, the high costs of surgery will likely hinder market growth over the forecast period.
Vertebral Augmentation Market Trends
Kyphoplasty Segment Expected to Register a Significant CAGR Over the Forecast Period
Kyphoplasty involves injecting a special cement into the vertebrae and making space for the procedure with a balloon-like device (balloon vertebroplasty). Kyphoplasty can restore the height of a damaged vertebra and possibly alleviate pain. The kyphoplasty devices segment is expected to witness significant growth in the vertebral augmentation market over the forecast period owing to the increasing incidences of osteoporosis among the population and growing cases of cancer-damaged vertebrae or certain spinal fractures.
The kyphoplasty procedure is preferred for treating fractured vertebrae with minimal incisions due to several benefits over vertebroplasty procedures, including short-term pain relief, improvement of the short- and long-term kyphotic angle, lower cement leakage rate, improvement in mobility and quality of life, and for increasing vertebral body height as well as reduced kyphosis. For instance, according to an article published in Frontiers in Surgery Journal in July 2022, kyphoplasty is more frequently used to treat osteoporotic vertebral compression fractures, spinal metastatic tumors, hemangiomas, myelomas, and vertebral union.
In addition, kyphoplasty may be a safe and effective treatment for ankylosing spondylitis patients with thoracic or lumbar fractures caused by the intravertebral vacuum phenomenon. This procedure relieves pain, improves function, restores the anterior and middle height, and corrects the kyphotic angle of the fractured vertebra.
Similarly, as per an article published in Frontiers in Surgery in February 2022, it was observed that both percutaneous kyphoplasty (PKP) with or without posterior pedicle screw fixation (PPSF) can maintain the spinal sagittal balance and produce excellent clinical results. In addition, PKP demonstrated more substantial advantages in the early postoperative period than PPSF+KP. Thus, the above studies showed that kyphoplasty effectively treats vertebral fractures in patients, which is anticipated to fuel the segment’s growth over the forecast period.
Therefore, owing to the abovementioned factors, such as the advantages of kyphoplasty, the market studied is anticipated to grow over the forecast period.
North America Expected to Register Significant Market Growth Over the Forecast Period
North America is anticipated to hold a significant market share over the forecast period due to the high demand for vertebral augmentation procedures and the high burden of osteoporosis and spine injuries. The robust healthcare infrastructure and launches by various companies of new products in the region are also expected to impact the market significantly.
According to the data published by the American Association of Neurological Surgeons in 2023, vertebral compression fractures (VCF) are the most common fracture in patients with osteoporosis, affecting about 750 thousand people annually in the United States. In addition, an estimated 25% of all postmenopausal women are estimated to be affected by VCFs annually in the United States, and the prevalence of VCF steadily rises with age, affecting 40% of women aged 80 and older.
Additionally, as per the 2022 statistics published by Osteoporosis Canada, about 2.3 million Canadians are living with osteoporosis, and 80% of all fractures in people aged 50 years and above are caused by osteoporosis. Furthermore, according to the 2024 statistics published by the United Nations Population Fund, about 20% and 18% of the population were estimated to be 65 years and above in 2024 in Canada and the United States, respectively. Thus, a high percentage of the senior population is likely to develop osteoporosis, raising the risk of vertebral fractures. This is anticipated to fuel the demand for augmentation procedures, propelling market growth.
Moreover, the rising product approvals in the region increase the availability of technologically advanced novel products, which is also expected to fuel market growth. For instance, in September 2022, Stryker received the US Food and Drug Administration’s (FDA) approval for its OptaBlate bone tumor ablation system (OptaBlate). This approval assisted the company in expanding its core competencies in vertebral augmentation and radiofrequency ablation and completing its portfolio of treatment options for metastatic vertebral body fractures.
Therefore, owing to the abovementioned factors, such as the high burden of vertebral fractures and osteoporosis among the population, new product approvals, and the growing aging population, the market studied is anticipated to grow over the forecast period.
Vertebral Augmentation Industry Overview
The vertebral augmentation market is highly consolidated, with a few major players operating globally. These market players are conducting various clinical studies to develop more sophisticated procedures, which are expected to boost the market's growth. Some of the key companies in the market are Medtronic, Johnson & Johnson, Stryker Corporation, Globus Medical Inc., Merit Medical Systems Inc., BMK Global Medical Company, IZI Medical Products, and Zavation.
Vertebral Augmentation Market Leaders
-
Johnson & Johnson
-
Stryker Corporation
-
Globus Medical, Inc
-
Merit Medical Systems, Inc
-
Medtronic PLC
*Disclaimer: Major Players sorted in no particular order
Vertebral Augmentation Market News
- June 2024: Amber Implants successfully enrolled participants in its inaugural human clinical trial for the VCFix Spinal System. This groundbreaking system offers a cement-free solution for vertebral compression fractures, a departure from traditional methods.
- June 2023: Aster CMI Hospital conducted Vertebral Stentoplasty, a novel vertebral augmentation procedure, on a 57-year-old female patient.
Vertebral Augmentation Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 High Prevalence of Osteoporosis and Injuries due to Accidents and Sports
- 4.2.2 Rising Geriatric Population
- 4.2.3 Technological Advancements and Ongoing Research in the Area
-
4.3 Market Restraints
- 4.3.1 High Cost of Surgeries
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Product
- 5.1.1 Vertebroplastic Device
- 5.1.2 Kyphoplastic Device
-
5.2 By End User
- 5.2.1 Hospitals
- 5.2.2 Ambulatory Surgery Centers
- 5.2.3 Other End Users
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Medtronic PLC
- 6.1.2 Johnson & Johnson
- 6.1.3 Alphatec Spine Inc.
- 6.1.4 Stryker Corporation
- 6.1.5 Globus Medical Inc.
- 6.1.6 Merit Medical Systems Inc.
- 6.1.7 BIOPSYBELL SRL
- 6.1.8 IZI Medical Products LLC
- 6.1.9 RONTIS
- 6.1.10 Zavation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityVertebral Augmentation Industry Segmentation
As per the report's scope, vertebral augmentation is a minimally invasive, image-guided surgical method. It is used for curing vertebral compression fracture and other spinal injuries, which leads to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping.
The vertebral augmentation market is segmented by product, end user, and geography. By product, the market is segmented into vertebroplastic device and kyphoplastic device. By end user, the market is segmented into hospitals, ambulatory surgery centers, and other end users. The other end users segment includes specialty care centers, orthopedic clinics, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report covers the estimated market sizes and trends for 17 countries globally. The report offers the value (in USD) for the above segments.
| By Product | Vertebroplastic Device | |
| Kyphoplastic Device | ||
| By End User | Hospitals | |
| Ambulatory Surgery Centers | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Vertebral Augmentation Market Research FAQs
What is the current Vertebral Augmentation Market size?
The Vertebral Augmentation Market is projected to register a CAGR of 4.20% during the forecast period (2024-2029)
Who are the key players in Vertebral Augmentation Market?
Johnson & Johnson, Stryker Corporation, Globus Medical, Inc, Merit Medical Systems, Inc and Medtronic PLC are the major companies operating in the Vertebral Augmentation Market.
Which is the fastest growing region in Vertebral Augmentation Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Vertebral Augmentation Market?
In 2024, the North America accounts for the largest market share in Vertebral Augmentation Market.
What years does this Vertebral Augmentation Market cover?
The report covers the Vertebral Augmentation Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vertebral Augmentation Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vertebral Augmentation Industry Report
Statistics for the 2024 Vertebral Augmentation market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vertebral Augmentation analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
